Your browser doesn't support javascript.
loading
Utility of an artificial intelligence system for classification of esophageal lesions when simulating its clinical use.
Tajiri, Ayaka; Ishihara, Ryu; Kato, Yusuke; Inoue, Takahiro; Matsueda, Katsunori; Miyake, Muneaki; Waki, Kotaro; Shimamoto, Yusaku; Fukuda, Hiromu; Matsuura, Noriko; Egawa, Satoshi; Yamaguchi, Shinjiro; Ogiyama, Hideharu; Ogiso, Kiyoshi; Nishida, Tsutomu; Aoi, Kenji; Tada, Tomohiro.
Afiliación
  • Tajiri A; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Ishihara R; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan. ryu1486@gmail.com.
  • Kato Y; AI Medical Service Inc, Tokyo, Japan.
  • Inoue T; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Matsueda K; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Miyake M; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Waki K; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Shimamoto Y; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Fukuda H; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Matsuura N; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Egawa S; Department of Gastroenterology, Keio University Hospital, Tokyo, Japan.
  • Yamaguchi S; Department of Gastroenterology, Osaka Police Hospital, Osaka, Japan.
  • Ogiyama H; Department of Gastroenterology, Kansai Rosai Hospital, Hyogo, Japan.
  • Ogiso K; Departments of Gastroenterology and Hepatology, Itami City Hospital, Osaka, Japan.
  • Nishida T; Department of Gastroenterology, JR Osaka Railway Hospital, Osaka, Japan.
  • Aoi K; Department of Gastroenterology, Toyonaka Municipal Hospital, Osaka, Japan.
  • Tada T; Department of Gastroenterology, Kaizuka City Hospital, Osaka, Japan.
Sci Rep ; 12(1): 6677, 2022 04 23.
Article en En | MEDLINE | ID: mdl-35461350
ABSTRACT
Previous reports have shown favorable performance of artificial intelligence (AI) systems for diagnosing esophageal squamous cell carcinoma (ESCC) compared with endoscopists. However, these findings don't reflect performance in clinical situations, as endoscopists classify lesions based on both magnified and non-magnified videos, while AI systems often use only a few magnified narrow band imaging (NBI) still images. We evaluated the performance of the AI system in simulated clinical situations. We used 25,048 images from 1433 superficial ESCC and 4746 images from 410 noncancerous esophagi to construct our AI system. For the validation dataset, we took NBI videos of suspected superficial ESCCs. The AI system diagnosis used one magnified still image taken from each video, while 19 endoscopists used whole videos. We used 147 videos and still images including 83 superficial ESCC and 64 non-ESCC lesions. The accuracy, sensitivity and specificity for the classification of ESCC were, respectively, 80.9% [95% CI 73.6-87.0], 85.5% [76.1-92.3], and 75.0% [62.6-85.0] for the AI system and 69.2% [66.4-72.1], 67.5% [61.4-73.6], and 71.5% [61.9-81.0] for the endoscopists. The AI system correctly classified all ESCCs invading the muscularis mucosa or submucosa and 96.8% of lesions ≥ 20 mm, whereas even the experts diagnosed some of them as non-ESCCs. Our AI system showed higher accuracy for classifying ESCC and non-ESCC than endoscopists. It may provide valuable diagnostic support to endoscopists.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón